Andreas Gedeon

CEO

Mr. Gedeon, a former Officer in the German Navy, graduated with a Bachelor in Educational Science from the University of the German Federal Armed Forces Munich in 2000. He is an experienced entrepreneur and businessman with proven expertise in large-scale and HR intensive projects. His previous areas of business include media production and commercial construction.

As the founder of United Greeneries and Satipharm, Mr. Gedeon became Managing Director of MMJ Phytotech (ASX: MMJ) at the time of the merger with Phytotech Therapeutics in July 2015.

Lisa Dea

CFO

Ms. Dea has over 20 years of experience in the finance, securities and accounting fields. Ms. Dea has been the CFO of several TSX and TSX-V listed companies where she was responsible for corporate strategy, all aspects of finance and legal, debt and capital market activities, internal and external public reporting, financial controls, processes and corporate governance. She has been instrumental in helping several companies grow from the development stage to large-scale commercial operations. Prior to her time in industry, Lisa spent eleven years at Deloitte & Touche LLP, achieving the position of Senior Manager. Ms. Dea obtained her Chartered Accountants designation in 1997 and also holds a B.Comm from the University of British Columbia.

Nick Maltchev

CTO and Interim COO

Mr. Maltchev is a global executive with a passion for results and building great teams. He brings a mix of strategic thinking and deep technical knowledge and over 25 years of technology experience. He has been involved with the industry since 2004 and was an integral part of the Advanced Nutrients management team over a period of 12 years, holding several positions including information technology manager, COO and general manager. Mr. Maltchev holds a BBA degree, as well as other designations in project management, cybersecurity and computer science. He is also currently in the process of finishing an MBA in management information systems.

Daniela Vaschi

CEO United Greeneries

Daniela Vaschi is an Organizational Psychologist from the European Union with more than ten years of multidisciplinary experience, including over 6 years at the corporate level within global operations. She has a successful background in developing business structures from ground zero, as well as rebuilding infrastructure after mergers and acquisitions, downsizing and turnarounds. Her past work experience includes a track record of leading complex improvement initiatives in the automotive industry. She is an active member of the International Organization Development Association, performing an ongoing meta-analytic research on Emotional Intelligence.

Jonathan Hartshorn

CEO of Satipharm

Jonathan holds a degree in Pharmacology and Physiology and is a Fellow of the Institute of Chartered Accountants. He has over 15 years experience in the Life Sciences arena, including Discovery, Development, Clinical Trials and OTC/ Grocery retail experience, as well as transaction experience including M&A and financings. He has held key leadership positions in Pfizer Consumer Healthcare Ireland, McNeil Healthcare and Venn Life Sciences Plc.

Andreas Gedeon

CEO and Managing Director

Mr. Gedeon, a former Officer in the German Navy, graduated with a Bachelor in Educational Science from the University of the German Federal Armed Forces Munich in 2000. He is an experienced entrepreneur and businessman with proven expertise in large-scale and HR intensive projects. His previous areas of business include media production and commercial construction.

As the founder of United Greeneries and Satipharm, Mr. Gedeon became Managing Director of MMJ Phytotech (ASX: MMJ) at time of the merger with Phytotech Therapeutics in July 2015. Mr. Gedeon currently oversees the global expansion strategy of the MMJ group.

Peter Wall

Chairman

Peter Wall is a corporate lawyer based in Perth, Western Australia and is a Partner at one of Australia’s leading corporate and commercial law firms. He was a founding director and shareholder in Phytotech Medical Limited, the first medical cannabis company to list on the Australian Securities Exchange, which subsequently was renamed “MMJ Phytotech Ltd” after a merger with MMJ Biosciences Inc.